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CLAYSON suggested that certain aromatic amines act as bladder carcinogens
as a consequence of their metabolic conversion to ortho-hydroxylated derivatives
and considerable evidence has accumulated in support of this view (Claysoii,
1962). Amongst the ortho-hydroxylated amines believed to be bladder carcino-
gens are certain tryptophan metabolites such as, 3-hydroxykynurenine and 3-
hydroxyanthranilic acid, and it has been suggested that the urinary excretion of
these compounds may cause " spontaneous " bladder tumours in main (Allein,
Boyland, Dukes, Horning and Watson, 1957). Abul-Fadl and Khalafallah (1961)
have shown an association ofain abnormally high incidence ofbladder tumours and
a raised level of urinary excretion of 3-hydroxyanthranilic acid in bilharziasis.
In view of the possible importance of ortho-aminophenols in the induction of
bladder tumours in man, Boyland, Wallace and Williams (1957) suggested that
glucosaccharo-l1 4-lactone might be used to inhibit urinary glucuronidase aild
thus minimise the formation of free ortho-aminophenols in the bladder.
Unfortunately the glucuronides are not the only conjugates, which could
give rise to free ortho-aminophenols in the bladder (Boyland, Kinder, Manson
and Ramsev, 1959). The in vivo inhibition of ortho-hydroxylation seemed to be a
promising approach to the problem, particularlv in view of the observation that
riboflavin appeared to strongly inhibit the formationi of phenolic metabolites
from the hydrocarboni benzopyrene in the mouse (Harper and Calcutt, 1961).
2-Naphthylamine was a suitable amine for study as its ortho-hydroxylated
metabolites, 2-amino-i-naphthol and its conjugates, could be conveniently
estimated using the method of Clayson (1950). A seconid group of carcinogenic
metabolites, 2-naphthylhydroxylamine and its conjugates, (Boyland, Dukes
and Grover, 1961) are produced from 2-naphthylamine. Under the conditions
employed in Clayson's method 2-naphthylhydroxylamine is converted to 2-
amino-i-naphthol (Boyland, Manson and Nery, 1960), although not quantita-
tively, but as only small amounts of naphthylhydroxylamine derivatives appear
to be formed the method gives a reasoinable estimate of the excretion of 2-amino-
1-naphthol and its conjugates.
It is ofinterest that acetylation in vivo of the amino group of 2-naphthvlamine
seems to inhibit ortho-hydroxylation and favour the formationi of 6-hvdroxv
derivatives (Williams, 1959). Clayson (1950) found that dogs fed 2-naphthy-
lamine excreted 30-70 per cent of the dose as 2-amino-i-niaphthol derivatives, but
when fed 2-acetamidonaphthalene less than 5 per cent of the dose was excreted
as 1-hvdroxy derivatives.F. DEWHURST
MATERIALS AND METHODS
The animals used were 12-16 weeks old, strong A mice drawn from stocks held
in this department and fed upon a commercial pelleted diet. No animal was
used in more than one experiment.
In the feeding experiments the mice were given a diet of powdered pellets,
mixed with 0 2 per cent of finely powdered 2-naphthylamine, made into balls
with a minimum amount of water. The diet was made up freshly each day as it
tended to discolour on keeping. The animals were given the diet ad libitum for
7 days, starved for 18 hours and allowed food for 6 hours and then injected intra-
peritoneally (I.P.) with 0.1 ml. of " Beflavit " (0.5 mg. of riboflavin) or 0*1 ml. of
" Dummy ". Beflavit is a concentrated commercial preparation of riboflavin
dissolved up in a solvent which, in all probability, is an aqueous solution of some
compound which forms a water soluble molecular complex with riboflavin.
Dummy was the solvent alone.
After injection the animals were placed in groups of 10 in metabolism cages
and the urine collected for 18 hours after which the animals were given food for
6 hours and returned to the metabolism cages for a further 18 hours. This was
continued for a total of 3 days. The experiment was repeated three times with
two groups of animals receiving Beflavit and two Dummy on each occasion.
In other experiments groups of about 5 animals were taken and injected I.P.
with water or potential inhibitor solutions, followed an hour later by 2 mg. each
of 2-naphthylamine hydrochloride as a 0 2 per cent aqueous solution. The
groups were then placed in metabolism cages and the urine collected for the
following 18 hours. In some experiments the animals received the 2-naphthy-
lamine hydrochloride by stomach tube as a 1 per cent aqueous solution.
The amount of 2-amino-1-naphthol and its conjugates in the urine samples
was determined as described previously (Dewhurst, 1963a). The determinations
were performed in duplicate. Probabilities (P) were calculated by means of
Student's " t " function. In the feeding experiments probabilities were calcula-
ted taking duplicate determinations as two separate values but in all other experi-
ments the mean of a pair of duplicate determinations was taken as a single value.
It was found from blank experiments on urine samples from animals treated
with the potential inhibitors, but not 2-naphthylamine that the small " blank "
value found for urine from untreated mice was not affected by any ofthe potential
inhibitors.
Liver sections were fixed in Heidenhain's Susa mixture and stained with
haemotoxylin and eosin.
RESULTS
Preliminary experiments showed that the bulk of a dose of 2-naphthylamine
whether given by mouth or I.P injection was rapidly excreted. No 2-aminol-
1-naphthol was detectable in mouse urine voided more than 18 hours after dosing.
In the experiments with the potential inhibitors no significant difference was
found between aninals treated with Beflavit and Dummy or between animals-
given an aqueous solution of riboflavin or water. Significant differences in
excretion of 2-amino-i -naphthol derivatives were observed on comparison of
animals, treated with SKF-525-A (diethylaminoethyl diphenylpropylacetate), or
chlorpromazine or with Dummy, with animals of the same sex given pure water.
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No significant differences were observed with any ofthe other compounds studied.
The results of these experiments are recorded in Tables I, II and III.
TABLE I.-The Urinary Excretion of 2-Amino-1-Naphthol and its Conjugates
from Female Micefed 0-2 per cent 2-Naphthylamine in their Diet
gg. of 2-amino-l-naphthol hydrochloride per mouse.
Mice injected I.P. with
Days after , - i
injection 01- ml. Beflavit 01- ml. Dummy
1 . 216±78 179±65
0-4>P>0 3
2 236± 105
3 . 220±69
0 50>P>0 40
0. 60>P>0-50
205±71
242+72
TABLE II.-The Urinary Excretion of 2-Amino-1-Naphthol and its Conjugates
from Mice Injected I.P. with 2 mg. of 2-Naphthylamine
Potential inhibitor given
per mouse (1 hour before the
naphthylamine and
in 1 ml. of water
unless otherwise
stated)
1 ml. Water
400 pg. 2,4-Dinitrophenol
10 mg. Ascorbic acid
500pg. Codeine phosphate
24 hours before the
amine
1 mg. Aspirin 24 hours
before the amine
1 ml. Water
1 mg. Aspirin
500 pug. Codeine phosphate
1 mg. SKF-525-A
1 mg. Pyridoxine hydro-
chloride
100 pug. Riboflavin
2 mg. Nicotinamide
I -25 mg. Chlorpromazine
(0 05 ml. May and
Baker Largactil)
0 I ml. Dummy
0.-1 ml. Beflavit
Fg. of
2-amino-
1-naphthol
hydrochloride
excreted per
mouse
368±98
297 +72
2894-96
422±80
481± 154
396±59
468±42
320±48
191±72
464±67
450±112
517±107
105±68
195±85
230±30
Probability
(P)
0*3>P>0*2
0-3>P>0-2
0-4>P>0*3
0-2>P>0K1
0G4>P>0-3
0. 1>P>0*05
0-002>P>0-001
0-2>P>0O1
0*5>P>0 4
0-2>P>0-1
0-002>P>0-001
0-01>P>0-002
0-5>P>0 4
TABLE III.-The Urinary Excretion of 2-Amino-l-Naphthol and its Conjugates
from Mice given 2 mg. of 2-Naphthylamine by Stomach Tube
Potential inhibitor
given per mouse
(1 hour before dose of
naphthylamine)
1 ml. Water
1 -25 mg. Chlorpromazine
-pg. of
2-amino-
1-naphthol
hydrochloride
excreted
per mouse
618±193
216±88
Probability
(P)
0 002>P>0- 001
Number
and sex
of animals
49M.
20M.
20M.
25M.
25M.
30F.
24F.
24F.
25F.
30F.
31F.
29F.
21F.
23F.
18F.
Number
and sex
of animals
32F.
32F.
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No pathological changes were obvious in the livers of mice 24 hours after
treatment with any of the agents which significantly inhibited the excretion of 2-
amino-l-naphthol and its conjugates.
DISCUSSION
It has been reported (Axelrod, Udenfriend and Brodie, 1954) that ascorbic
acid is involved in the hydroxylation of such compounds as acetanilide, but no
evidence was found in the present work that it is involved in the formation of
2-amino-1-naphthol derivatives from 2-naphthylamine.
Nicotinamide is the end product of the metabolic pathway in which 3-hydro-
xykynurenine and 3-hydroxyanthranilic acid are formed from tryptophane and
its use as a potential inhibitor of the formation of these compounds has been
suggested (Abul-Fadl and Khalafallah, 1961). The lack of any significant inhibi-
tion of the ortho-hydroxylation of 2-naphthylamine suggests that if end product
inhibition of the conversion of tryptophan to nicotinamide occurs it is without
influence upon the ortho-hydroxylation of aromatic amines foreign to normal
metabolism.
Pyridoxal is thought to form in vivo Schiff's bases with the amino group of
amino acids. In view of the effect of acetylation upon the ortho-hydroxylation of
2-naphthylamine it seems reasonable to expect that if Schiff's base formation
occurs in vivo with 2-naphthylamine a significant inhibition of the formation of
2-amino-l-naphthol and its conjugates would be observed. The lack of any such
inhibition suggests that pyridoxal plays no part in the metabolism of naphthy-
lamine.
The complete lack of any inhibition of the ortho-hydroxylation of 2-naphthy-
lamine by riboflavin is rather surprising, as this implies from the observations of
Harper and Calcutt (1961), that the mechanism of hydroxylation of benzo-
pyrene is radically different from that of 2-naphthylamine.
2.4-Dinitrophenol is known to have a powerful effect upon oxidative phos-
phorylation and its lack of influence upon the ortho-hydroxylation of 2-naphthy-
lamine suggests that oxidative phosphorylation is not directly linked to the process.
Chlorpromazine has been shown in inhibit in vitro a number of microsomal
drug metabolising enzymes (Kato, Chiesara and Vassanelli, 1962a) and fiom the
present work it would appear capable of inhibition in vivo.
It has been shown that 2-naphthylamine is metabolised by a microsomal
NADPH2 dependent enzyme system (Booth and Boyland, 1956). In view of the
fact that chlorpromaziine is metabolised by a similar enzyme system the effects
of codeine and aspirin, two relatively harmless compounds which are also meta-
bolised by similar enzyme systems, were also examined. The lack of any inhibi-
tioin with these compounds implies that chlorpromazine does not act as an in-
hibitor of 2-naphthvlamines ortho-hydroxylation by competition for co-factors
such as NADPH2.
It is well known that mainy compounds can cause an inicrease in the activity of
microsomal enzyme systems and it has been shown that the system involved in
the ortho-hydroxylation of 2-naphthylamine is stimulated by 1,2 5,6-dibenzaii-
thracene (Dewhurst, 1963b). It has been found in preliminary studies that 20-
methylcholanthrenie, nikethamide and 3,4-benzopyrene also appear to stimulate
the ortho-hydroxylation of 2-naphthylamine in rats. In the case of rats given 25
mg. of 3,4-benzopyrene I.P. in ethvl oleate the exeretioni of 2-amino-1-naphthol
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and its conjugates appeared to be still raised 12 days after the hydrocarbon inijec-
tion. In view of the very widespread use of aspirin and codeine their effects on
naphthylamine metabolism, 24 hours after dosing, were examined. The absence
of any stimulation of 2-amino-i-naphthol excretion implies that the use of aspirin
and codeine is not contra-indicated by exposure to carcinogenic amines.
The well marked inhibition produced by Dummy is probably associated with
the toxicity of the solution. About 10 per cent of mice injected with 0 2 ml. of
the Dummy solution died.
The compound SKF-525-A is known to inhibit a wide range of microsomal
enzyme systems including some involved in the hydroxylation of aromatic com-
pounds (Brodie, Gillette and La Du, 1958). It is of interest in view of the lack of
inhibition found with riboflavin and 2-naphthylamine, when riboflavin strongly
inhibits the hydroxylation of 3,4-benzopyrene, that SKF-525-A is reported
(Conney, Miller and Miller, 1957) to inhibit in vitro benzopyrene hydroxylase by
less than 15 per cent.
An ideal inhibitor for prophylactic use would be cheap and free from side
effects. None of the compounds which significantly inhibited the ortho-hydroxy-
lation of 2-naphthylamine seemed suitable for prophylactic use. Dummy was
toxic, chlorpromazine has a wide range ofside effects and in the case ofSKF-525-A
it has been found that an initial inhibition of microsomal metabolic activity is
often followed by a stimulation (Kato, Chiesara and Vassanelli, 1962b).
SUMMARY
The effects of a number of potential inhibitors upon the ortho-hydroxylation of
2-naphthylamine have been studied. Significant inhibition of the excretion of
2-amino-1-naphthol and its conjugates was observed with SKF-525-A, chlor-
promazine anid Dummy Beflavit.
No inhibition was observed with riboflavin, ascorbic acid, nicotinamide,
pyridoxine hydrochloride, 2,4-dinitrophenol, aspirin, or codeine phosphate.
No significant stimulation of excretion was observed with any of the com-
pounds.
The significance of these results was discussed.
The costs of this work were defrayed from a block granit from the British
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